5, 2024 /PRNewswire/ -- Evernorth Health Services announced that it plans to have a Stelara biosimilar available for $0 out of pocket for eligible patients of its specialty pharmacy, Accredo ...

BLOOMFIELD, Conn., Sept. 5, 2024 /PRNewswire/ -- Evernorth Health Services announced that it plans to have a Stelara biosimilar available for $0 out of pocket for eligible patients of its specialty ...

Estimated to save individual Accredo patients around $4,000 per year Biosimilar price will be more than 80% lower than Stelara list price Accredo patients benefit from the specialty pharmacy's best-in ...

TRICARE is coming under fire for its decision to renew a multibillion-dollar contract to Express Scripts to manage the U.S. military’s health care program’s pharmacy benefits. Independent ...

Ensuring prescriptions for limited-distribution drugs are filled in-network via an in-house specialty pharmacy enables close integration between the pharmacy and care teams which ultimately leads ...

When pharmacies reject those terms, more Tricare patients turn to Accredo, a specialty pharmacy, “which is prone to delays and safety issues, but drives more profits to parent company Cigna ...

For many employers, unions, municipalities and other health plan sponsors that choose to work with Accredo as part of their specialty pharmacy network offering, this represents an opportunity for ...

Walgreens announced this week that it is expanding its specialty pharmacy offerings to include cell and gene therapy services. The move could allow Walgreens to play a bigger role in a growing ...

Walgreens (WBA) is standing up a new specialty pharmacy segment to compete in an increasingly crowded pharmacy benefits manager (PBM) and specialty pharmacy space. The company announced Thursday ...

"Not all biosimilars are created equal," Matt Perlberg, president of Cigna's Evernorth Health Services' pharmacy and care ... per year for some of the 100,000 Accredo patients currently using ...